Board of Advisors |
|
Professor Steven Myint MD, PhD - Dr. Myint is Founding Partner of Innovatum and Ukko Partners, both of which supported the development
of Finnish biotech companies. He is also chairman of Plexpress Oy and Inc, a Finnish biotech company with a US subsidiary and non-executive
director of Aplagon Oy. He is owner and director of Moewin Associates which provides consultancy to the health and biopharmaceutical industries.
He is also Senior fellow and advisor to A-star, the government research agency in Singapore. He is also Chairman of Inex Private Ltd.. In
addition, he is a partner in the Palo Alto based venture fund, Pharma Capital. Until recently he was also executive chairman of Green Signal
Bio, one of India’s largest vaccine manufacturers. He is a former Professor and Dean of Medicine & Health at the University of Surrey and
Professor of Microbiology & Immunology at the University of Leicester in the UK. He has been a global Medical Director at GlaxoSmithKline and
Senior Vice-President for R&D/Chief Medical Officer at BTG International. He is also a former Senior Independent Director/chairman in the NHS
in the UK and Board Member of Care International, and was executive chairman of Onmedica Group Ltd and Onmedica India Private Ltd. He has also
been Chief Executive of the European Federation of Neurological Associations. He has authored over 120 peer reviewed publications and 6 books.
He was also Editor-in-Chief of the Journal of Infection for 5 years. He is a Fellow or Member of several societies, including the Institute of
Knowledge Transfer, the Royal College of Physicians and the Royal Society of Medicine. After his own first university spinout in 2005, he has
been involved in the development of over 20 SME’s in life sciences and created over $1 billion value for shareholders.
|
